SCHEMBL972961

SCHEMBL972961

CNCC(=O)N(C)c1nccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.43
NR3C1 P04150 1/20 0.40
ALDH1A1 P00352 2/20 0.38
PKM P14618 2/20 0.38
TRPM8 Q7Z2W7 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
PPARG P37231 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
LMNA P02545 2/20 0.34
ADRB2 P07550 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
HDAC1 Q13547 2/20 0.34
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13545685 0.81 FFAR2 (0.46) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL22481561 0.80 FFAR2 (0.48) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL2936251 0.79 FFAR2 (0.49) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL9942595 0.79 FFAR2 (0.44) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL27630421 0.78 FFAR2 (0.46) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL18969622 0.77 FFAR2 (0.43) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL30088848 0.76 ALDH1A1 (0.43) FFAR2NR3C1ALDH1A1PKMTRPM8
SCHEMBL14591145 0.75 FFAR2 (0.49) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL17198163 0.74 FFAR2 (0.43) FFAR2NR3C1ALDH1A1PKMSMN1; SMN2
SCHEMBL13359498 0.74 FFAR2 (0.48) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871999-B2 Substituted thiazoles and their use for producing drugs GRUENENTHAL GMBH (DE) 2011-01-18 US disclosed
EP-1968957-B1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2010-01-20 EP disclosed
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-07-09 US disclosed
WO-2007079960-A9 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2008-10-23 WO disclosed
EP-1968957-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079960-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS TPMT, SLC5A2, DPP4 FFAR2 2613/4885NR3C1 1523/4885ALDH1A1 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.